|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 113, Issue 3 857-865, Copyright © 1991 by Company of Biologists
JOURNAL ARTICLES |
P Schmid, A Lorenz, H Hameister and M Montenarh
Department of Biochemistry, University of Ulm, Federal Republic of Germany.
By in situ hybridisation we have examined the expression of p53 during mouse embryogenesis from day 8.5 to day 18.5 post coitum (p.c.). High levels of p53 mRNA were detected in all cells of the day 8.5 p.c. and 10.5 p.c. mouse embryo. However, at later stages of development, expression became more pronounced during differentiation of specific tissues e.g. of the brain, liver, lung, thymus, intestine, salivary gland and kidney. In cells undergoing terminal differentiation, the level of p53 mRNA declined strongly. In the brain, hybridisation signals were also observed in postmitotic but not yet terminally differentiated cells. Therefore, gene expression of p53 does not appear to be linked with cellular proliferation in this organ. A proposed role for p53 in cellular differentiation is discussed.
This article has been cited by other articles:
|
|
 |
|
  C. S. Chen and P. G. Wells Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E Carcinogenesis, July 1, 2006; 27(7): 1358 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rivera and S. A. Maxwell The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway J. Biol. Chem., August 12, 2005; 280(32): 29346 - 29354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Saifudeen, V. Diavolitsis, J. Stefkova, S. Dipp, H. Fan, and S. S. El-Dahr Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION J. Biol. Chem., June 17, 2005; 280(24): 23094 - 23102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Daftarian, G.-Y. Song, S. Ali, M. Faynsod, J. Longmate, D. J. Diamond, and J. D. I. Ellenhorn Two Distinct Pathways of Immuno-Modulation Improve Potency of p53 Immunization in Rejecting Established Tumors Cancer Res., August 1, 2004; 64(15): 5407 - 5414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Vinson and B. F. Hales Genotoxic Stress Response Gene Expression in the Mid-Organogenesis Rat Conceptus Toxicol. Sci., July 1, 2003; 74(1): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Saifudeen, J. Marks, H. Du, and S. S. El-Dahr Spatial repression of PCNA by p53 during kidney development Am J Physiol Renal Physiol, October 1, 2002; 283(4): F727 - F733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schreiber, J.-C. Ame, P. Dolle, I. Schultz, B. Rinaldi, V. Fraulob, J. Menissier-de Murcia, and G. de Murcia Poly(ADP-ribose) Polymerase-2 (PARP-2) Is Required for Efficient Base Excision DNA Repair in Association with PARP-1 and XRCC1 J. Biol. Chem., June 14, 2002; 277(25): 23028 - 23036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Stenn and R. Paus Controls of Hair Follicle Cycling Physiol Rev, January 1, 2001; 81(1): 449 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C D'Sa-Eipper, J. Leonard, G Putcha, T. Zheng, R. Flavell, P Rakic, K Kuida, and K. Roth DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3 Development, January 1, 2001; 128(1): 137 - 146. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Porrello, M. A. Cerone, S. Coen, A. Gurtner, G. Fontemaggi, L. Cimino, G. Piaggio, A. Sacchi, and S. Soddu p53 Regulates Myogenesis by Triggering the Differentiation Activity of pRb J. Cell Biol., December 11, 2000; 151(6): 1295 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Dey, R. P. Bronson, J. Dahl, J. P. Carroll, and T. L. Benjamin Accelerated Development of Polyoma Tumors and Embryonic Lethality: Different Effects of p53 Loss on Related Mouse Backgrounds Cell Growth Differ., May 1, 2000; 11(5): 231 - 237. [Abstract] [Full Text]
|
|
|
|
|
|
X. Liu, E. A. Peralta, J. D. I. Ellenhorn, and D. J. Diamond Targeting of Human p53-overexpressing Tumor Cells by an HLA A*0201-restricted Murine T-Cell Receptor Expressed in Jurkat T Cells Cancer Res., February 1, 2000; 60(3): 693 - 701. [Abstract] [Full Text]
|
|
|
|
|
|
C. L. Nutt, N. A. Loktionova, A. E. Pegg, A. F. Chambers, and J.g. Cairncross O6-Methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes Carcinogenesis, December 1, 1999; 20(12): 2361 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Komarov, E. A. Komarova, R. V. Kondratov, K. Christov-Tselkov, J. S. Coon, M. V. Chernov, and A. V. Gudkov A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy Science, September 10, 1999; 285(5434): 1733 - 1737. [Abstract] [Full Text]
|
|
|
|
|
|
P. Ruiz-Lozano, M. L. Hixon, M. W. Wagner, A. I. Flores, S. Ikawa, A. S. Baldwin Jr., K. R. Chien, and A. Gualberto p53 Is a Transcriptional Activator of the Muscle-specific Phosphoglycerate Mutase Gene and Contributesin Vivo to the Control of Its Cardiac Expression Cell Growth Differ., May 1, 1999; 10(5): 295 - 306. [Abstract] [Full Text]
|
|
|
|
|
|
A. Cederberg, M. Hulander, P. Carlsson, and S. Enerback The Kidney-expressed Winged Helix Transcription Factor FREAC-4 Is Regulated by Ets-1. A POSSIBLE ROLE IN KIDNEY DEVELOPMENT J. Biol. Chem., January 1, 1999; 274(1): 165 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Moallem and B. Hales The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations Development, January 8, 1998; 125(16): 3225 - 3234. [Abstract] [PDF]
|
|
|
|
|
|
S. Ernstsson, S. Pierrou, M. Hulander, A. Cederberg, M. Hellqvist, P. Carlsson, and S. Enerback Characterization of the Human Forkhead Gene FREAC-4. EVIDENCE FOR REGULATION BY WILMS' TUMOR SUPPRESSOR GENE (WT-1) AND p53 J. Biol. Chem., August 30, 1996; 271(35): 21094 - 21099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L A Godley, J B Kopp, M Eckhaus, J J Paglino, J Owens, and H E Varmus Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes & Dev., April 1, 1996; 10(7): 836 - 850. [Abstract] [PDF]
|
|
|
|
|
|
S. Parker, G Eichele, P Zhang, A Rawls, A. Sands, A Bradley, E. Olson, J. Harper, and S. Elledge p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells Science, February 17, 1995; 267(5200): 1024 - 1027. [Abstract] [PDF]
|
|
|
|
|
|
H Pan and A E Griep Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes & Dev., June 1, 1994; 8(11): 1285 - 1299. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Sakuragi, H. Matsuo, G. Coukos, E. E. Furth, M. P. Bronner, C. M. VanArsdale, S. Krajewsky, J. C. Reed, and J. F. Strauss Differentiation-Dependent Expression of the BCL-2 Proto-Oncogene in the Human Trophoblast Lineage Reproductive Sciences, April 1, 1994; 1(2): 164 - 172. [Abstract] [PDF]
|
|
|
|
|
|
W. B. Derry, A. P. Putzke, and J. H. Rothman Caenorhabditis elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance Science, October 19, 2001; 294(5542): 591 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-m. Mu, Y.-x. Liu, L. L. Collins, E. Kim, and C. Chang The p53/Retinoblastoma-mediated Repression of Testicular Orphan Receptor-2 in the Rhesus Monkey with Cryptorchidism J. Biol. Chem., July 28, 2000; 275(31): 23877 - 23883. [Abstract] [Full Text] [PDF]
|
|
